France remedies pharmaceutical deal following EU referral
France’s Competition Authority has conditionally approved Phoenix Group’s €1.5 billion acquisition of McKesson’s European businesses, after asking the European Commission for permission to review national aspects of a deal for only the fourth time.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.